Updated process for American Headache Society Guidelines

Same authorSame journal

Potential role of tirzepatide, a dual GLP-1 and GIP receptor agonist, for preventive treatment of migraine: A case series.

Headache·2026

Same author

College students' migraine perceptions and lived experiences: A qualitative study.

Headache·2026

Same author

A patient-centered conceptual model and measurement framework for migraine experience developed by the Migraine Clinical Outcome Assessment System.

Headache·2026

Same author

Evaluating the relationship between the 4-item migraine interictal burden scale and other patient-reported outcome measures: a <i>post hoc</i> analysis from a phase 3 migraine prevention study.

Frontiers in neurology·2026

Same author

Treatment outcomes in new daily persistent headache in children and adolescents.

Cephalalgia : an international journal of headache·2026

Same author

Message From the Editors to Our Reviewers.

Neurology·2026

Same journal

Biochemical profiling and symptomatology of androgen deficiency in males with cluster headache: A prospective case-control study.

Headache·2026

Same journal

Thiamine deficiency in patients with chronic migraine: A case-control study.

Headache·2026

Same journal

Potential association of cluster headache with certain COVID-19 vaccines: An assessment from the pharmacovigilance databases.

Headache·2026

Same journal

Adverse childhood experiences, migraine, and adverse pregnancy outcomes among teenage mothers.

Headache·2026

Same journal

Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension study.

Headache·2026

Related Experiment Videos

Updated process for American Headache Society Guidelines

Related Concept Videos

Potential role of tirzepatide, a dual GLP-1 and GIP receptor agonist, for preventive treatment of migraine: A case series.

College students' migraine perceptions and lived experiences: A qualitative study.

A patient-centered conceptual model and measurement framework for migraine experience developed by the Migraine Clinical Outcome Assessment System.

Evaluating the relationship between the 4-item migraine interictal burden scale and other patient-reported outcome measures: a <i>post hoc</i> analysis from a phase 3 migraine prevention study.

Treatment outcomes in new daily persistent headache in children and adolescents.

Message From the Editors to Our Reviewers.

Biochemical profiling and symptomatology of androgen deficiency in males with cluster headache: A prospective case-control study.

Thiamine deficiency in patients with chronic migraine: A case-control study.

Potential association of cluster headache with certain COVID-19 vaccines: An assessment from the pharmacovigilance databases.

Adverse childhood experiences, migraine, and adverse pregnancy outcomes among teenage mothers.

Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension study.

Related Experiment Videos

Updated process for American Headache Society Guidelines

Related Concept Videos

Related Articles

Potential role of tirzepatide, a dual GLP-1 and GIP receptor agonist, for preventive treatment of migraine: A case series.

College students' migraine perceptions and lived experiences: A qualitative study.

A patient-centered conceptual model and measurement framework for migraine experience developed by the Migraine Clinical Outcome Assessment System.

Evaluating the relationship between the 4-item migraine interictal burden scale and other patient-reported outcome measures: a <i>post hoc</i> analysis from a phase 3 migraine prevention study.

Treatment outcomes in new daily persistent headache in children and adolescents.

Message From the Editors to Our Reviewers.

Biochemical profiling and symptomatology of androgen deficiency in males with cluster headache: A prospective case-control study.

Thiamine deficiency in patients with chronic migraine: A case-control study.

Potential association of cluster headache with certain COVID-19 vaccines: An assessment from the pharmacovigilance databases.

Adverse childhood experiences, migraine, and adverse pregnancy outcomes among teenage mothers.

Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension study.